About David MacMillan
Form D filings for Graviton BioScience from 2023 to 2024 list David MacMillan as director.
David MacMillan first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David MacMillan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David MacMillan works with at each company, as listed on that company's latest Form D.
Graviton BioScience Corp · Form D, Feb 14, 2024
SW
Samuel Waksal
Chief Executive Officer and director
BC
Bihua Chen
Director
JL
Jeremy Levin
Director
JB
James Boylan
Director
SP
Stelios Papadopoulos
Director
RN
Ran Nussbaum
Director